Former FDA, CMS heads commend importation, government negotiation to control drug prices

In an editorial published in JAMA, former FDA Commissioner Robert Califf and former CMS Acting Administrator Andrew Slavitt endorsed a wide range of policies to reduce drug costs, including targeted importation, cutting supply chain and marketing costs, government

Read the full 384 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE